Toyama, Japan

Toshiya Sugino

This inventor holds 1 USPTO granted patent. Top assignees: Ikeda Mohando Company, Ltd., Otsuka Pharmaceutical Company, Limited. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiya Sugino. Retrieved from https://idiyas.com/inventor/toshiya-sugino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshiya Sugino: Innovator in Heterocyclic Compounds

Introduction

Toshiya Sugino is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. His work has implications for medical applications, especially in treating peptic ulcers.

Latest Patents

Sugino holds a patent for heterocyclic compounds, specifically compounds of Formula I, where X and Y can be independently --NH--, --O--, or --S--. Z may represent a pyrimidine, triazine, triazole, thiazole, or thiadiazole ring. The methods of preparation for these compounds are also described in his patent. These compounds are recognized for their potential use as antipeptic ulcer agents. He has 1 patent to his name.

Career Highlights

Throughout his career, Sugino has worked with prominent companies in the pharmaceutical industry. He has been associated with Ikeda Mohando Company, Ltd. and Otsuka Pharmaceutical Company, Limited. His work in these organizations has contributed to advancements in medicinal chemistry.

Collaborations

Sugino has collaborated with notable colleagues, including Fujio Nohara and Tomoaki Fujinawa. Their joint efforts have furthered research and development in their respective fields.

Conclusion

Toshiya Sugino's contributions to the field of heterocyclic compounds highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…